 Zynerba Pharmaceuticals NASDAQ:ZYNE Inc said it will deliver oral and poster presentations on its CBD gel Zygel at the American Society of Clinical Psychopharmacology Annual Meeting ASCP 2022, held this week in Scottsdale, Arizona. The oral presentation will focus on the demonstrated long-term safety and potential effectiveness of Zygel in children and adolescents with Fragile X syndrome, and the poster presentation will highlight design enhancements incorporated into its RECONNECT trial, the company said. 